Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.

Autor: Lamers RED; Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands. Electronic address: romy.lamers@gmail.com., van der Wijden FC; Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., de Angst IB; Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., de Vries M; Institute for Computing and Information Sciences (iCIS) and Social and Cultural Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands., Cuypers M; Department of Primary and Community Care, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands., van Melick HHE; Department of Urology, St. Antonius Hospital, Nieuwegein, the Netherlands., de Beij JS; Department of Urology, Zuyderland Medical Centre, Heerlen, the Netherlands., Oerlemans DJAJ; Department of Urology, Laurentius Hospital, Roermond, the Netherlands., van de Beek K; Department of Urology, Maastricht UMC+, Maastricht, the Netherlands., Bosch RJLHR; Department of Urology, University Medical Center Utrecht, Utrecht, the Netherlands., Kil PJM; Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.
Jazyk: angličtina
Zdroj: Urology [Urology] 2020 Mar; Vol. 137, pp. 138-145. Date of Electronic Publication: 2019 Dec 30.
DOI: 10.1016/j.urology.2019.12.026
Abstrakt: Objective: To evaluate treatment preferences of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) before and after using a web-based decision aid (DA).
Patients and Methods: Between July 2016 and January 2017 patients were invited to use a web-based LUTS/BPH DA. Treatment preferences (for lifestyle advices, medication or surgery) before and after DA use and responses on values clarification exercises were extracted from the DA.
Results: In total, 126 patients were included in the analysis. Thirty-four percent (43/126) had not received any previous treatment and were eligible for (continuation of) lifestyle advices or to start medication, as initial treatment. The other 66% (83/126) did use medication and were eligible, either for continuing medication or to undergo surgery. Before being exposed to the DA, 67 patients (53%) were undecided and 59 patients (47%) indicated an initial treatment preference. Half of the patients who were initially undecided were able to indicate a preference after DA use (34/67, 51%). Of those with an initial preference, 80% (47/59) confirmed their initial preference after DA use. Five out of 7 values clarification exercises used in the DA were discriminative between final treatment preferences. In 79%, the treatment preferred after DA use matched the received treatment. Overall, healthcare providers were positive about DA feasibility.
Conclusion: Our findings suggest that a LUTS/BPH DA may help patients to confirm their initial treatment preference and support them in forming a treatment preference if they did not have an initial preference.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: